Medsense
"Turning Tests Into Lasting Connections
Introduction
In 2026, Medsense will focus on gaining market traction through the deployment of our platform in four diagnostic labs — two in Bulgaria and two in Mexico. These labs serve as pilot sites aligned with our “Crossing the Chasm” go-to-market strategy. The selected clinics and labs are innovators eager to solve the long-standing problem of low patient follow-up, which affects over 30% of diagnostic outcomes.
The primary goal is to convert missed diagnostics into lasting connections through AI-driven behavioral nudges and operational automation. In parallel, we will build relationships with Canadian private clinics and longevity-focused centers, setting the stage for expansion in 2027.
Problem
Despite 70% of medical decisions depending on diagnostic data, critical operational and behavioral gaps exist:
30% of abnormal results receive no timely follow-up.
65% of lab errors occur before results (ordering, collection).
20% of tests are unnecessary, wasting resources and reducing impact.
These gaps lead to:
Poor patient adherence
Missed revenue opportunities for labs
Higher risk for patients and inefficiencies for providers
[Source: Medsense Whitepaper, WHO, CDC, Deloitte]
Opportunity
Medsense is the intelligent layer for diagnostics, focused on improving follow-up and re-engagement.
Key Features:
Behavioral nudges: Personalized, automated messages to prompt follow-up
Risk stratification: Identifies and prioritizes high-risk patients
1-click follow-up: Integrated patient pathways with referrals and alerts
Low-friction integration: Works with spreadsheets, APIs, or messaging apps
Data-driven dashboards: For clinics to track engagement and adherence
Impact:
25% operational expense reduction
2x faster result-to-action turnaround
15% increase in recurring revenue
[Source: Medsense Reference Document]